You just read:

Compugen Announces Publication of Two Peer-Reviewed Papers Demonstrating the Role of PVRIG as a Novel Immune Checkpoint for Cancer Immunotherapy

News provided by

Compugen Ltd.

Jan 22, 2019, 07:00 ET